myNEO Therapeutics’ CEO, Cedric Bogaert, recently won a spot on the Forbes30under30 List 2023! We are very honored and excited about this achievement. Here is what he had to say about earning the spot.
“What started out 6 years ago as experimenting with some early datasets and patient samples, turned out into a rapidly growing biotech business in Ghent, bringing together some of the smartest minds and most ambitious spirits. We’re constantly analyzing tumors, getting smarter at understanding them, and improving the current state of the art in immunotherapy developments. The technology we developed not only resulted in scientific publications pushing the knowledge boundaries, but also led to biopharma deals that allow us to tap into resources and knowledge all across the world for our mission: Unlocking the potential of cancer immunotherapies with data-driven innovation for each and every patient.“, says Cedric Bogaert.
We thank all the amazing colleagues, the great team of advisors and partners, and anyone else who has supported us throughout the years.